Loading: 100%
THERMO FISHER SCIENTIFIC INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Waltham, United States of AmericaWaltham, United States of Americano data available
Employees 55,000 (as per Q1 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker TMOno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17120140160180200
datesClosing price (adj.)
13.10.2017192.42
11.10.2017193.46
04.10.2017193.51
27.09.2017188.47
20.09.2017188.60
13.09.2017191.32
06.09.2017189.26
30.08.2017182.81
23.08.2017175.67
16.08.2017175.30
09.08.2017173.12
02.08.2017176.30
26.07.2017174.92
19.07.2017180.01
12.07.2017180.06
05.07.2017175.60
27.06.2017173.56
20.06.2017175.53
13.06.2017174.79
06.06.2017175.78
30.05.2017172.97
23.05.2017171.55
16.05.2017171.99
09.05.2017171.84
02.05.2017166.98
25.04.2017158.58
18.04.2017153.02
11.04.2017152.62
04.04.2017152.47
28.03.2017154.39
21.03.2017155.29
14.03.2017158.08
07.03.2017156.85
28.02.2017157.27
21.02.2017158.22
14.02.2017156.87
07.02.2017152.62
31.01.2017152.00
24.01.2017140.62
17.01.2017144.68
10.01.2017147.40
03.01.2017143.30
27.12.2016142.04
19.12.2016140.89
12.12.2016144.66
05.12.2016140.87
28.11.2016139.81
21.11.2016145.64
14.11.2016147.49
07.11.2016151.26
31.10.2016146.50
24.10.2016152.56
17.10.2016150.24
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
192.42n/a
Market Capitalisation
in million USD
75,279n/a
Enterprise Value
in million USD
92,221n/a
Common Shares Outstanding
as per Apr 1, 2017
391,219,918n/a
Preferred Shares Outstanding
as per Apr 1, 2017
n/a
Average Basic Shares Outstanding
TTM
393,600,000n/a
Average Diluted Shares Outstanding
TTM
396,250,000n/a
Index Membership
n/a
Business Summary
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 17,973n/a
Gross Profit 8,199n/a
Operating Income 2,575n/a
EBITDA 4,284n/a
Net Profit 1,995n/a
Balance Sheet
Cash and Cash Equivalents 1,970n/a
Receivables 2,895n/a
Total Current Assets 8,204n/a
PP&E 2,599n/a
Total Assets 48,011n/a
Accounts Payable 942n/a
Current Debt 1,972n/a
Total Current Liabilities 5,260n/a
Long-Term Debt 16,940n/a
Total Liabilities 26,352n/a
Total Equity 21,659n/a
Cash Flow
Depreciation & Amortisation 1,709n/a
Change in Working Capital 88n/a
Operating Cash Flow 3,179n/a
Net Change in PP&E and Intangibles -407n/a
Investing Cash Flow -5,955n/a
Dividends Paid -239n/a
Financing Cash Flow 4,308n/a
Total Change in Cash 1,467n/a
Free Cash Flow 4,010n/a
Profitability Ratios
Gross Margin 45.6%n/a
Operating Margin 14.3%n/a
Net Profit Margin 11.1%n/a
Return on Equity 9.2%n/a
Return on Assets 4.2%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 21.53n/a
EV/Sales 5.13n/a
Book to Market Value 0.29n/a
Other Ratios
Current Ratio 156.0%n/a
Liabilities to Equity Ratio 121.7%n/a
Debt to Assets Ratio 39.4%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
9,746
10,498
9,912
10,393
11,559
12,510
13,090
16,890
16,965
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-5,942
-6,292
-6,014
-6,132
-6,765
-7,214
-7,561
-9,398
-9,210
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
3,804
4,206
3,898
4,262
4,794
5,296
5,529
7,492
7,756
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-2,788
-2,941
-2,837
-3,013
-3,447
-3,731
-3,842
-5,587
-5,304
Selling, General & Administrative
-2,549
-2,692
-2,593
-2,729
-3,107
-3,355
-3,446
-4,896
-4,612
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-239
-249
-244
-284
-340
-376
-396
-691
-692
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
1,017
1,265
1,061
1,248
1,347
1,564
1,687
1,905
2,452
Non-Operating Income (Loss)
-114
-101
-122
-100
-118
-213
-290
-416
-400
Interest Expense, net
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-114
-101
-122
-100
-118
-213
-290
-416
-400
Pretax Income (Loss), Adjusted
903
1,163
940
1,148
1,229
1,352
1,397
1,489
2,052
Abnormal Gains (Losses)
-42
-35
-59
-60
-97
-82
-78
598
-115
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
861
1,128
880
1,088
1,133
1,269
1,320
2,087
1,936
Income Tax (Expense) Benefit, net
-94
-153
-57
-102
-109
-11
-40
-192
44
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
767
975
823
986
1,023
1,258
1,279
1,896
1,980
Net Extraordinary Gains (Losses)
-19
6
27
50
307
-81
-6
-1
-5
Discontinued Operations
-19
6
27
50
307
-81
-6
-1
-5
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
748
981
850
1,036
1,330
1,178
1,273
1,894
1,975
Minority Interest
0
0
0
0
0
0
0
0
0
Net Income
748
981
850
1,036
1,330
1,178
1,273
1,894
1,975
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
748
981
850
1,036
1,330
1,178
1,273
1,894
1,975
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
1,288
1,571
926
1,021
810
5,831
1,344
452
Cash & Cash Equivalents
n/a
1,281
1,564
917
1,016
806
5,826
1,344
452
Short Term Investments
n/a
8
7
9
4
4
5
0
0
Accounts & Notes Receivable
n/a
1,478
1,410
1,474
1,764
1,805
1,942
2,474
2,545
Accounts Receivable, Net
n/a
1,478
1,410
1,474
1,764
1,805
1,942
2,474
2,545
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
1,171
1,131
1,173
1,330
1,443
1,495
1,860
1,992
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
408
419
562
708
777
613
863
753
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
162
160
181
158
182
193
303
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
247
259
381
550
595
421
560
753
Total Current Assets
n/a
4,346
4,531
4,135
4,822
4,835
9,881
6,540
5,741
Property, Plant & Equipment, Net
n/a
1,275
1,333
1,360
1,611
1,726
1,767
2,427
2,449
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
15,469
15,761
15,854
20,401
20,883
20,215
33,886
32,644
Intangible Assets
n/a
6,423
6,337
5,914
7,816
7,805
7,071
14,110
12,758
Goodwill
n/a
8,678
8,983
8,996
11,973
12,475
12,503
18,843
18,828
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
368
441
945
611
604
641
933
1,058
Total Noncurrent Assets
n/a
16,744
17,094
17,214
22,012
22,610
21,983
36,312
35,093
Total Assets
n/a
21,090
21,625
21,349
26,834
27,445
31,863
42,852
40,834
Liabilities and owners' equity
Payables & Accruals
n/a
869 868600000
848 848000000
851 851200000
937 936700000
1,029 1029400000
1,124 1123500000
1,655 1654700000
1,633 1632900000
Accounts Payable
n/a
540 539500000
534 533600000
547 546700000
612 612300000
641 641400000
692 691500000
821 820700000
822 822200000
Accrued Taxes
n/a
33 32900000
28 28400000
0 0
0 0
0 0
0 0
165 165100000
213 212500000
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
296 296200000
286 286000000
305 304500000
324 324400000
388 388000000
432 432000000
669 668900000
598 598200000
Short Term Debt
n/a
15 14800000
118 117500000
106 105800000
1,273 1272800000
93 93100000
988 987700000
2,212 2212400000
1,052 1051800000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
657 656800000
674 673800000
753 752800000
904 903600000
971 970800000
1,015 1014800000
1,483 1482700000
1,462 1461600000
Deferred Revenue
n/a
135 135300000
140 139800000
158 158200000
193 192500000
197 196500000
199 198900000
312 311900000
318 317900000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
522 521500000
534 534000000
595 594600000
711 711100000
774 774300000
816 815900000
1,171 1170800000
1,144 1143700000
Total Current Liabilities
n/a
1,540 1540200000
1,639 1639300000
1,710 1709800000
3,113 3113100000
2,093 2093300000
3,126 3126000000
5,350 5349800000
4,146 4146300000
Long Term Debt
n/a
2,003 2003200000
2,064 2064000000
2,031 2031300000
5,755 5755200000
7,031 7031200000
9,500 9499600000
12,352 12351600000
11,420 11420200000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
2,620 2620100000
2,491 2490800000
2,247 2247300000
2,927 2927300000
2,855 2855400000
2,382 2381700000
4,603 4602600000
3,918 3917600000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
1,994 1994200000
1,934 1933800000
1,626 1626100000
2,229 2229300000
2,047 2047200000
1,610 1609900000
3,431 3430700000
2,623 2622600000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
626 625900000
557 557000000
621 621200000
698 698000000
808 808200000
772 771800000
1,172 1171900000
1,295 1295000000
Total Noncurrent Liabilities
n/a
4,623 4623300000
4,555 4554800000
4,279 4278600000
8,683 8682500000
9,887 9886600000
11,881 11881300000
16,954 16954200000
15,338 15337800000
Total Liabilities
n/a
6,164 6163500000
6,194 6194100000
5,988 5988400000
11,796 11795600000
11,980 11979900000
15,007 15007300000
22,304 22304000000
19,484 19484100000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
11,723 11723100000
11,565 11564600000
10,422 10421500000
10,558 10558400000
10,915 10914600000
8,592 8592200000
11,882 11882100000
12,213 12213100000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-151 -151300000
-577 -576500000
-491 -490500000
-1,837 -1837100000
-2,997 -2996800000
-412 -412200000
-456 -455900000
-1,008 -1007900000
Retained Earnings
n/a
3,501 3500500000
4,351 4350800000
5,386 5386400000
6,716 6716300000
7,697 7697300000
8,753 8753300000
10,407 10406900000
12,142 12142300000
Other Equity
n/a
-146 -145800000
92 92000000
44 43600000
-400 -399500000
-150 -150400000
-77 -77200000
-1,285 -1285000000
-1,997 -1997300000
Equity Before Minority Interest
n/a
14,927 14926500000
15,431 15430900000
15,361 15361000000
15,038 15038100000
15,465 15464700000
16,856 16856100000
20,548 20548100000
21,350 21350200000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
14,927 14926500000
15,431 15430900000
15,361 15361000000
15,038 15038100000
15,465 15464700000
16,856 16856100000
20,548 20548100000
21,350 21350200000
Total Liabilities & Equity
n/a
21,090 21090000000
21,625 21625000000
21,349 21349400000
26,834 26833700000
27,445 27444600000
31,863 31863400000
42,852 42852100000
40,834 40834300000
Remarks restated on n/a restated on Feb 26, 2010 n/a restated on Feb 24, 2011 n/a restated on Feb 29, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 27, 2014 n/a restated on Feb 26, 2015 n/a restated on Feb 25, 2016 n/a restated on Nov 4, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
748
981
822
989
1,328
1,197
1,279
1,896
1,980
Net Income
748
981
850
1,036
1,330
1,178
1,273
1,894
1,975
Net Income From Discontinued Operations
0
0
-28
-47
-2
19
6
1
5
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
757
793
763
740
860
984
1,000
1,685
1,688
Non-Cash Items
-50
-55
-129
-140
-271
-102
-422
-1,174
-444
Stock-Based Compensation
51
57
67
82
80
78
91
117
125
Deferred Income Taxes
-99
-131
-243
-267
-123
-302
-473
-622
-525
Other Non-Cash Adjustments
-2
20
47
45
-228
122
-40
-669
-44
Change in Working Capital
30
-297
156
-138
-240
-11
159
218
-399
(Increase) Decrease in Accounts Receivable
-10
-51
125
-71
-101
12
-148
-145
-149
(Increase) Decrease in Inventories
-14
-50
108
-24
-29
-60
-72
-110
-141
Increase (Decrease) in Accounts Payable
7
-124
-45
-1
34
10
47
1
-3
Increase (Decrease) in Other
47
-73
-32
-42
-144
27
332
472
-107
Net Cash From Discontinued Operations (operating)
-2
-2
47
48
14
-28
-5
-4
-9
Cash from Operating Activities
1,484
1,420
1,659
1,498
1,691
2,040
2,011
2,620
2,817
Change in Fixed Assets & Intangibles
-156
-249
-187
-235
-253
-302
-262
-378
-405
Disposition of Fixed Assets & Intangibles
19
15
13
10
8
13
21
49
18
Disposition of Fixed Assets
19
15
13
10
8
13
21
49
18
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
-176
-264
-200
-245
-261
-315
-282
-428
-423
Purchase of Fixed Assets
-176
-264
-200
-245
-261
-315
-282
-428
-423
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
1
9
20
2
8
89
12
Decrease in Long Term Investment
8
0
1
9
20
2
8
89
12
Increase in Long Term Investment
-8
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-493
-198
-633
-606
-5,677
-1,083
-11
-11,538
-695
Net Cash from Divestitures
0
4
4
0
14
0
0
1,522
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
-493
-202
-637
-606
-5,690
-1,083
-11
-13,060
-695
Other Investing Activities
32
-11
-4
-10
22
-46
2
45
0
Net Cash From Discontinued Operations (investing)
31
8
-8
-16
746
59
0
0
0
Cash from Investing Activities
-586
-450
-830
-859
-5,142
-1,371
-263
-11,783
-1,087
Dividends Paid
0
0
0
0
0
-142
-216
-235
-241
Cash From (Repayment of) Debt
-473
-152
-200
-373
4,709
102
3,355
1,876
-1,933
Cash From (Repayment of) Short Term Debt, net
-464
-20
-637
-609
457
-825
188
-287
50
Cash From (Repayment of) Long Term Debt, net
-9
-131
437
236
4,253
928
3,167
2,163
-1,982
Repayments of Long Term Debt
-10
-131
-312
-505
-1
-355
-1
-4,429
-3,780
Cash From Long Term Debt
1
0
748
741
4,254
1,282
3,168
6,592
1,798
Cash From (Repurchase of) Equity
-553
-102
-360
-935
-1,179
-896
141
3,097
-376
Increase in Capital Stock
345
85
54
77
158
254
230
3,097
124
Decrease in Capital Stock
-898
-187
-415
-1,013
-1,338
-1,150
-90
0
-500
Other Financing Activities
97
25
3
13
21
18
31
57
58
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-929
-228
-558
-1,295
3,551
-918
3,310
4,796
-2,491
Net Cash Before Disc. Operations and FX
-31
742
272
-656
99
-249
5,057
-4,367
-762
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-31
742
272
-656
99
-249
5,057
-4,367
-762
Effect of Foreign Exchange Rates
-11
-86
11
9
0
38
-37
-116
-130
Net Changes in Cash
-42
655
284
-647
99
-211
5,020
-4,483
-891
Remarks
restated on Feb 26, 2010 n/a
calculated values,
restated on Feb 24, 2011 n/a
calculated values,
restated on Feb 29, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 26, 2015 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 25, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo